Tekla Healthcare Investors (HQH) 24.82 $HQH Tekla World

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tekla Healthcare Investors (HQH) 24.82 $HQH

Tekla World Healthcare Fund Paid Distribution
BusinessWire - Thu Jun 30, 9:50AM CDT
On June 30, 2016, Tekla World Healthcare Fund paid a monthly stock distribution of $0.1167 per share. It is currently estimated that this distribution is derived from short term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized depreciation of portfolio securities and net realized gains on sale of securities is -$82,086,490, of which $105,403,333 represents net unrealized depreciation of portfolio securities.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Healthcare Investors Paid Distribution
BusinessWire - Thu Jun 30, 9:50AM CDT
On June 30, 2016, Tekla Healthcare Investors paid a distribution of $0.49 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $277,274,083 of which $253,627,722 represents net unrealized appreciation of portfolio securities.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Healthcare Opportunities Fund Paid Distribution
BusinessWire - Thu Jun 30, 9:50AM CDT
On June 30, 2016, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that $0.0366 of this distribution is derived from short-term capital gains and $0.0759 is derived from net investment income. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized depreciation of portfolio securities and net realized gains on sale of securities is -$37,252,488, of which $53,001,203 represents net unrealized depreciation of portfolio securities.
HQL: 18.13 (-0.01), THQ: 16.71 (+0.04), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Funds Announce Results of Joint Annual Shareholders Meeting
BusinessWire - Tue Jun 14, 1:02PM CDT
The Boards of Trustees of Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW) are pleased to announce the results from the Funds' annual shareholder meeting held today.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Life Sciences Investors Paid Distribution
BusinessWire - Fri Jun 10, 9:48AM CDT
On June 10, 2016, Tekla Life Sciences Investors paid a distribution of $0.37 per share. It is currently estimated that this distribution is derived from long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $92,430,063, of which $96,890,977 represents net unrealized appreciation of portfolio securities.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Healthcare Investors Declares Stock Distribution
BusinessWire - Mon May 16, 2:04PM CDT
On May 16, 2016, Tekla Healthcare Investors declared a stock distribution of $0.49 per share. The record date for the stock distribution is May 26, 2016 and the payable date is June 30, 2016. The Fund will trade ex-distribution on May 24, 2016.
HQH: 24.82 (+0.22)

H&Q Healthcare Investors Down 20.6% Since SmarTrend Downtrend Call (HQH)
Comtex SmarTrend(R) - Fri Apr 01, 1:25AM CDT
SmarTrend identified a Downtrend for H&Q Healthcare Investors (NYSE:HQH) on December 4th, 2015 at $30.22. In approximately 4 months, H&Q Healthcare Investors has returned 20.57% as of today's recent price of $24.00.
HQH: 24.82 (+0.22)

Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program
BusinessWire - Thu Mar 24, 3:12PM CDT
Tekla Life Sciences Investors (the "Fund" announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2016. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2017. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Healthcare Investors Announce Renewal of Share Repurchase Program
BusinessWire - Thu Mar 24, 3:12PM CDT
Tekla Healthcare Investors (the "Fund" announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2016. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2017. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.
THQ: 16.71 (+0.04), HQL: 18.13 (-0.01), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

Tekla Healthcare Opportunities Fund Announces Share Repurchase Program
BusinessWire - Thu Mar 24, 3:12PM CDT
Tekla Healthcare Opportunities Fund (the "Fund" announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 10, 2016. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period ending July 10, 2017. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.
HQL: 18.13 (-0.01), THQ: 16.71 (+0.04), THW: 14.36 (+0.20), HQH: 24.82 (+0.22)

H&Q Healthcare Investors Shares Down 23.3% Since SmarTrend's Sell Call (HQH)
Comtex SmarTrend(R) - Thu Mar 24, 12:54PM CDT
SmarTrend identified a Downtrend for H&Q Healthcare Investors (NYSE:HQH) on December 4th, 2015 at $30.22. In approximately 4 months, H&Q Healthcare Investors has returned 23.26% as of today's recent price of $23.19.
HQH: 24.82 (+0.22)

Shares of HQH Down 21.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 04, 5:29PM CST
SmarTrend identified a Downtrend for H&Q Healthcare Investors (NYSE:HQH) on December 4th, 2015 at $30.22. In approximately 3 months, H&Q Healthcare Investors has returned 21.63% as of today's recent price of $23.68.
HQH: 24.82 (+0.22)

23.1% Return Seen to Date on SmarTrend H&Q Healthcare Investors Call (HQH)
Comtex SmarTrend(R) - Thu Feb 04, 1:34PM CST
SmarTrend identified a Downtrend for H&Q Healthcare Investors (NYSE:HQH) on December 4th, 2015 at $30.22. In approximately 2 months, H&Q Healthcare Investors has returned 23.08% as of today's recent price of $23.24.
HQH: 24.82 (+0.22)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Korea Tourism’s Quiz Offers Free Trip Sweepstakes

Updated Category News Views 4

A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...

Continue Reading
NOARK: Powering Data Centers with Global-Local Approach

Updated Category News Views 3

The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
Zoomlion Boosts Mining Gear Amid Global Revenue Surge

Updated Category News Views 3

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

Continue Reading
CenterPoint Deploys Crews for Hurricane Aid Relief

Updated Category News Views 2

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...

Continue Reading
Jiangxi Dialogues: Youths Forge Global Ties in 2026

Updated Category News Views 3

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Continue Reading
India's Women Apparel Market Grows Amid Innovation

Updated Category News Views 4

India's Women Apparel Market on the Rise The winds of fashion change are sweeping through India, and the women's apparel market is at the heart of this sartorial hurricane. Set to explode from USD 28,786.82 million in 2024 to USD 45,491.96 million by 2032, this market is turning heads with a compound annual growth rate (CAGR) of 5.21%. What's stirring this pot, you ask?...

Continue Reading
Chianti Classico Showcases 2027 Vintages in Florence

Updated Category News Views 5

A Grand Reunion of the Black Rooster You're not just sipping wine at a garden party—you're diving into a historic event. Come March 1-2, 2027, Florence will again host the much-anticipated Chianti Classico Collection, uniting over 200 eager producers under the iconic vaults of Stazione Leopolda. This isn't just another stop on the wine circuit; it's a pilgrimage to the...

Continue Reading
Phoenix Scholar Examines AI and Institutional Trust

Updated Category News Views 2

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Continue Reading
FlyQuest & Von Dutch Link Gaming, Fashion Again

Updated Category News Views 5

Breaking Down Barriers in Fashion and Gaming In a world full of unlikely matches, the partnership between FlyQuest and Von Dutch is one that's catching serious eyeballs. FlyQuest, an esports powerhouse, has teamed up once more with the iconic fashion brand Von Dutch to launch "The Workman Collection." This ain't just about slapping logos on t-shirts and calling it a...

Continue Reading

Top 5 Most Recently Viewed Articles

First American Uranium's Strategic Expansion into Quebec's Mining Scene

Updated Category News Views 210

First American Uranium Inc. Expands into Quebec First American Uranium Inc. (CSE: URM) is set to announce its first significant strategic move into Quebec by planning the acquisition of five critical mineral properties in the Grenville Province. This region stands out as one of Canada's most promising areas for rare earths and niobium, characterized by its high...

Continue Reading
Valneva's IXCHIQ® Vaccine for Chikungunya Gains Approval

Updated Category News Views 185

Valneva's IXCHIQ® Vaccine Receives Canadian Approval Valneva SE, a company specializing in vaccine development, has successfully received marketing authorization from Health Canada for its single-dose chikungunya vaccine, IXCHIQ®. This approval is a significant step forward, particularly as it applies to individuals aged 12 years and older, extending the reach of the...

Continue Reading
Lotus Technology Secures Major Funding to Advance Mobility Innovations

Updated Category News Views 215

Lotus Technology’s Securing of Funding Commitment Lotus Technology Inc., a renowned player in the realm of intelligent and luxury mobility, has recently secured a substantial funding commitment totaling up to $300 million. This funding is designed to enhance the company’s operational flexibility and drive its continued growth as a leader in the high-end mobility...

Continue Reading
Lamar Advertising Revises Projections Following Mixed Earnings

Updated Category News Views 215

Lamar Advertising Updates Earnings Guidance Lamar Advertising Company (NASDAQ: LAMR) has recently revealed its earnings for the second quarter, presenting a mixture of results that have prompted a reassessment by analysts. While the company reported earnings per share of $1.52, significantly surpassing the analyst consensus estimate of 86 cents, its revenue fell short of...

Continue Reading
Upcoming Art Basel Qatar Showcases 87 Galleries in 2026

Updated Category News Views 399

Art Basel Qatar to Debut with 87 Diverse Galleries Art Basel Qatar is set to launch a remarkable exhibition in February 2026, showcasing an impressive array of 84 artistic presentations from 87 galleries. This much-anticipated event marks Art Basel's expansion into the Middle East and is expected to be a significant milestone in the global art scene, tailored to resonate...

Continue Reading